EP2082770A1 — Inhaler
Assigned to Vectura Delivery Devices Ltd · Expires 2009-07-29 · 17y expired
What this patent protects
An inhaler (10) comprising a housing (11) to receive a strip (14) having a plurality of blisters (14a), each blister having a puncturable lid (14c) and containing a dose of medicament for inhalation by a user, a mouthpiece (13) through which a dose of medicament is inhaled by a u…
USPTO Abstract
An inhaler (10) comprising a housing (11) to receive a strip (14) having a plurality of blisters (14a), each blister having a puncturable lid (14c) and containing a dose of medicament for inhalation by a user, a mouthpiece (13) through which a dose of medicament is inhaled by a user, a cap (12) to cover the mouthpiece and, a blister piercing element (16) to pierce the lid of a blister is disclosed. The cap is rotatable to drive the strip to sequentially move each blister into alignment with the blister piercing element and an actuator (18) is operable in response to rotation of the cap to cause the blister piercing element to puncture the lid of an aligned blister such that, when a user inhales through the mouthpiece, an airflow through the blister is generated to entrain the dose contained therein and carry it out of the blister and via the mouthpiece into the user's airway.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.